CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis

doi:10.3748/wjg.v6.i6.885

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2085)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

137

HTML

1825

Figures (1-2)

119

Sum=2081

Dec 15, 2000 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Dec 15, 2000; 6(6): 885-887
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.885

Open in New Tab Full Size Figure Download Figure

Figure 1 The ratio of CYP11B2/β-action presents the relative level of CYPP11B2.

Open in New Tab Full Size Figure Download Figure

Figure 2 Lanes 1: model group (week 4) β-actin; Lanes 9: model group (week 4) CYP11B2; Lanes 2: model group (week 8) β-actin; Lanes 8: model group (week 8) CYP11B2; Lanes 7: model group (week 10) CYP11B2; Lanes 4: control group β actin; Lanes 6: control group CYP11B2; Lanes 5: Makers

Citation: Li X, Meng Y, Yang XS, Wu PS, Li SM, Lai WY. CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis. World J Gastroenterol 2000; 6(6): 885-887
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/885.htm
DOI: https://dx.doi.org/10.3748/wjg.v6.i6.885